Skip to main content

SB 544 (2026)

Increase notification requirements for mid-year prescription drug coverage changes

This bill is still active.

Last updated 2026-03-15 6:37 pm
Summary:

Prohibits health insurers from modifying prescription drug formularies mid-year, requiring that any changes occur only at the time of coverage renewal. The bill also mandates continued coverage for previously approved drugs until the enrollee's plan renewal date.

The Senate rewrote the bill. The new bill allows health insurers from modifying prescription drug formularies mid-year, but extends the notification requirements from 45 days to 60 days before implementation and requires health insurers to more related information.

Bill Sponsor:
Donovan Fenton
Democratic party logo
Status:
SENATE
Public Hearing Date:
02/04/2026 09:00 am
Public Hearing Location:
SH Room 100
Senate Voting Date:
03/12/2026
Browse related articles and bills:
Thank you to our sponsors and donors